United States - English - NLM (National Library of Medicine)

travere therapeutics - chenodiol (unii: 0gei24lg0j) (chenodiol - unii:0gei24lg0j) - chenodiol 250 mg - chenodal (chenodiol tablets) is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. the likelihood of successful dissolution is far greater if the stones are floatable or small. for patients with nonfloatable stones, dissolution is less likely and added weight should be given to the risk that more emergent surgery might result from a delay due to unsuccessful treatment. safely of use beyond 24 months is not established. chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones. chenodal (chenodiol tablets) is contraindicated in the presence of known hepatocyte dysfunction or bile ductal abnormalities such as intrahepatic cholestasis, primary biliary cirrhosis or sclerosing cholangitis (see warnings ); a gallbladder confirmed as nonvisualizing after two consecutive single doses of dye; radiopaque stones; or gallstone complicatio

United States - English - NLM (National Library of Medicine)

manchester pharmaceuticals inc. - chenodiol (unii: 0gei24lg0j) (chenodiol - unii:0gei24lg0j) - chenodiol 250 mg - chenodal (chenodiol tablets) is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. the likelihood of successful dissolution is far greater if the stones are floatable or small. for patients with nonfloatable stones, dissolution is less likely and added weight should be given to the risk that more emergent surgery might result form a delay due to unsuccessful treatment. safety of use beyond 24 months is not established. chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones.

Ireland - English - HPRA (Health Products Regulatory Authority)

cp pharmaceuticals ltd trading as wockhardt uk - chenodeoxycholic acid - capsule - 125 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

cp pharmaceuticals ltd trading as wockhardt uk - chenodeoxycholic acid - tablets - 250 milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

artex limited - chenodeoxycholic acid 125mg - capsule - 125 mg - active: chenodeoxycholic acid 125mg

Philippines - English - FDA (Food And Drug Administration)

aldril pharmaceuticals, inc.; distributor: n/a - cefalexin (as monohydrate) - powder for suspension - 125 mg/5 ml

Philippines - English - FDA (Food And Drug Administration)

aldril pharmaceuticals, inc. - cefalexin (as monohydrate) - powder for suspension - 250 mg/5 ml

Philippines - English - FDA (Food And Drug Administration)

aldril pharmaceuticals, inc. - cefalexin (as monohydrate) - capsule - 500 mg

Philippines - English - FDA (Food And Drug Administration)

aldril pharmaceuticals, inc. - cefalexin (as monohydrate) - granules for suspension (oral drops) - 100mg/ ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

henda natural sdn bhd - radix angelica sinensis; radix rehmannia glutinosa; semen prunus persica; flos carthamus tinctorius; fructus citrus aurantium; radix paeoniae rubra; radix bupleurum chinense; radix glycyrrhiza glabra; radix platycodon grandiflorum; rhizoma ligusticum chuanxiong; radix cyathula officinalis -